VAICON 2013 – Jan 2013, Goa

Dr. Arun Bal is one of the most prominent diabetologists in India. He is a diabetic foot surgeon at Raheja Hospital, Mumbai. He is also the President of Diabetic Foot Society of India. The following Q&A dates back to 2007; however the issues addressed are equally relevant today.   Q I am a 55 year-old…

Smith and Nephew buys out Sushrut-Adler, a leading Indian manufacturer of orthopedic implants and instrumentation. This reflects the trend in the pharmaceutical industry of MNCs buying out Indian companies.

Our brand Easyfix celebrates 10 years. Like Xerox and Velcro, Easyfix has become synonymous with the entire cannula fixator category in India, and the brand that all others try to emulate. We look forward to another 10 years of growth and market leadership by Easyfix.

In August 2012 at the Clinical Infectious Diseases Society conference in Chennai, a road-map was laid out to tackle the problem of increasing resistance of bacteria to antibiotics. This is popularly known as the Chennai Declaration. It envisages that within 5 years, 90% of all antibiotics should be included in Schedule H1 and be sold…

The  Antimicrobial Discovery Center at Northeastern University in Boston, US announced the discovery of Teixobactin, the first new class of antibiotics in nearly 30 years.  The discovery is a breakthrough because bacteria are increasingly becoming resistant to existing antibiotics. The rampant misuse and overuse of antibiotics has been blamed for this increasing bacterial resistance. Also, pharmaceutical companies had…

ET has an interesting article by Karan Singh, a partner in the Healthcare practice at Bain. He estimates that by 2020, there will be 450 million people in the Urban Mass Market (other than the urban affluent). The estimated healthcare spend of this urban market is Rs 200,000 crores. He also recommends a less stringent…